Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Toledo Pons (PALMA DE MALLORCA, Spain). Obstructive Sleep Apnoea is a Pulmonary Embolism severity risk factor.. 326

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of Obstructive Sleep Apnea in Idiopathic Pulmonary fibrosis Source: International Congress 2018 – Obesity: comorbidities Year: 2018 The role of positive airway pressure treatment for Obstructive Sleep Apnea in Pulmonary Embolism Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Obstructive Sleep Apnea severity and lung function Source: International Congress 2018 – Diagnostics including questionnaires Year: 2018 Cognitive impairment in patients with Idiopathic Pulmonary Fibrosis - Obstructive Sleep Apnea Overlap Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD). Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Chronic Obstructive Pulmonary Disease Exacerbations Source: Eur Respir Rev 2009; 18: 305 Year: 2009 Obstructive sleep apnoea and risk of recurrent venous thromboembolism Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016 The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Is Obstructive Sleep Apnea a risk factor for Gestational Diabetes? Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Influence of Obstructive Sleep Apnea on systemic inflammation in pregnancy Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders Year: 2020 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 The ALONNISOS STUDY: Cross-sectional study of the prevalence of Obstructive Sleep Apnea Syndrome (OSAS) and Chronic Obstructive Pulmonary Disease (COPD) in the general population of Alonissos. Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Diagnosis of Moderate-to-severe Obstructive Sleep Apnea Syndrome based on the Sleep clinical record. Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019 Investigation of Obstructive Sleep Apnea in Adult Non-Cystic Fibrosis Bronchiectasis Patients Source: International Congress 2019 – Clinical problems Year: 2019 Minimal clinically important difference in Barthel dyspnoea after pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care Year: 2020